Analyst picks & changes

Liposome Technology Inc.

(LTIZ)

Matthew Geller of Oppenheimer & Co. reiterated a "buy", saying that adverse reactions in 21

Read the full 195 word article

How to gain access

Continue reading with a
two-week free trial.